Tags

Type your tag names separated by a space and hit enter

Effects of simvastatin on blood lipids, vitamin E, coenzyme Q10 levels and left ventricular function in humans.
Eur J Clin Invest. 2005 Apr; 35(4):251-8.EJ

Abstract

BACKGROUND

As statin therapy has been reported to reduce antioxidants such as vitamin E and coenzyme Q10 and there are indications that this reduction may cause impairment of left ventricular function (LVF), we studied the influence of simvastatin on LVF and serum vitamin E and coenzyme Q10 levels in humans.

MATERIAL AND METHODS

We assessed the effect of simvastatin on left ventricular function and coenzyme Q10 levels in 21 (11 male, 10 female) hypercholesterolaemic subjects (mean age = 56 years) with normal LVF, over a period of 6 months. Subjects were re-tested after a 1-month wash-out period (7 months). Echocardiography was performed on all subjects before commencement of simvastatin (20 mg day(-1)), and at 1, 3, 6 and 7 months after initiation of treatment. Fasting blood samples were also collected at these intervals to assess lipids, apoproteins, vitamin E and coenzyme Q10.

RESULTS

Serum lipids showed the expected reductions. Plasma vitamin E and coenzyme Q10 levels were reduced by 17 +/- 4% (P < 0.01) and 12 +/- 4% (P < 0.03) at 6 months. However, the coenzyme Q10/LDL-cholesterol ratio and vitamin E/LDL-cholesterol ratio increased significantly. Left ventricular ejection fraction (EF) decreased transiently after 1 month, while no significant change was observed at 3 and 6 months. Other markers of left ventricular function did not change significantly at any time point.

CONCLUSION

Despite reduced plasma vitamin E and coenzyme Q10, 20 mg of simvastatin therapy is associated with a significantly increased coenzyme Q10/LDL-cholesterol ratio and vitamin E/LDL-cholesterol ratio. Simvastatin treatment is not associated with impairment in left ventricular systolic or diastolic function in hypercholesterolaemic subjects after 6 months of treatment.

Authors+Show Affiliations

Greenslopes Private Hospital and The Wesley Hospital, Brisbane, Australia. d.colquhoun@uq.edu.auNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

15816994

Citation

Colquhoun, D M., et al. "Effects of Simvastatin On Blood Lipids, Vitamin E, Coenzyme Q10 Levels and Left Ventricular Function in Humans." European Journal of Clinical Investigation, vol. 35, no. 4, 2005, pp. 251-8.
Colquhoun DM, Jackson R, Walters M, et al. Effects of simvastatin on blood lipids, vitamin E, coenzyme Q10 levels and left ventricular function in humans. Eur J Clin Invest. 2005;35(4):251-8.
Colquhoun, D. M., Jackson, R., Walters, M., Hicks, B. J., Goldsmith, J., Young, P., Strakosch, C., & Kostner, K. M. (2005). Effects of simvastatin on blood lipids, vitamin E, coenzyme Q10 levels and left ventricular function in humans. European Journal of Clinical Investigation, 35(4), 251-8.
Colquhoun DM, et al. Effects of Simvastatin On Blood Lipids, Vitamin E, Coenzyme Q10 Levels and Left Ventricular Function in Humans. Eur J Clin Invest. 2005;35(4):251-8. PubMed PMID: 15816994.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Effects of simvastatin on blood lipids, vitamin E, coenzyme Q10 levels and left ventricular function in humans. AU - Colquhoun,D M, AU - Jackson,R, AU - Walters,M, AU - Hicks,B J, AU - Goldsmith,J, AU - Young,P, AU - Strakosch,C, AU - Kostner,K M, PY - 2005/4/9/pubmed PY - 2005/7/19/medline PY - 2005/4/9/entrez SP - 251 EP - 8 JF - European journal of clinical investigation JO - Eur J Clin Invest VL - 35 IS - 4 N2 - BACKGROUND: As statin therapy has been reported to reduce antioxidants such as vitamin E and coenzyme Q10 and there are indications that this reduction may cause impairment of left ventricular function (LVF), we studied the influence of simvastatin on LVF and serum vitamin E and coenzyme Q10 levels in humans. MATERIAL AND METHODS: We assessed the effect of simvastatin on left ventricular function and coenzyme Q10 levels in 21 (11 male, 10 female) hypercholesterolaemic subjects (mean age = 56 years) with normal LVF, over a period of 6 months. Subjects were re-tested after a 1-month wash-out period (7 months). Echocardiography was performed on all subjects before commencement of simvastatin (20 mg day(-1)), and at 1, 3, 6 and 7 months after initiation of treatment. Fasting blood samples were also collected at these intervals to assess lipids, apoproteins, vitamin E and coenzyme Q10. RESULTS: Serum lipids showed the expected reductions. Plasma vitamin E and coenzyme Q10 levels were reduced by 17 +/- 4% (P < 0.01) and 12 +/- 4% (P < 0.03) at 6 months. However, the coenzyme Q10/LDL-cholesterol ratio and vitamin E/LDL-cholesterol ratio increased significantly. Left ventricular ejection fraction (EF) decreased transiently after 1 month, while no significant change was observed at 3 and 6 months. Other markers of left ventricular function did not change significantly at any time point. CONCLUSION: Despite reduced plasma vitamin E and coenzyme Q10, 20 mg of simvastatin therapy is associated with a significantly increased coenzyme Q10/LDL-cholesterol ratio and vitamin E/LDL-cholesterol ratio. Simvastatin treatment is not associated with impairment in left ventricular systolic or diastolic function in hypercholesterolaemic subjects after 6 months of treatment. SN - 0014-2972 UR - https://www.unboundmedicine.com/medline/citation/15816994/Effects_of_simvastatin_on_blood_lipids_vitamin_E_coenzyme_Q10_levels_and_left_ventricular_function_in_humans_ L2 - https://doi.org/10.1111/j.1365-2362.2005.01486.x DB - PRIME DP - Unbound Medicine ER -